7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Apogee Therapeutics, Inc.
(NASDAQ:APGE) 

APGE stock logo

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc...

Founded: 2022
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
Apogee Therapeutics . Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.48-1.27-1.05-0.84-0.63-0.42-0.210
Apogee Therapeutics . Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.48-1.27-1.06-0.85-0.63-0.42-0.210
Apogee Therapeutics . Cash Per Share ttm
202311 202312 202401 202402 202403 202404 01.472.934.45.867.338.7910.26
Apogee Therapeutics . (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -34.27-29.37-24.48-19.58-14.69-9.79-4.90
Apogee Therapeutics . P/B ratio ttm
202311 202312 202401 202402 202403 202404 01.082.163.254.335.416.497.57
No extra charts and metrics for this ticker.